Frontlight ResearchEarly access
Lewy body dementia trials in Serbia
2 trials · From ClinicalTrials.gov, checked 19 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peoplePhase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
- Where
- Belgrade, Kragujevac
- Age
- 55 years to 84 years
- People
- 180 worldwide
- Run by
- ACADIA Pharmaceuticals Inc.
See details and how to joinNCT07029581 · EU 2025-521710-25-00 - Phase 3Taking peoplePhase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
- Where
- Belgrade, Kragujevac
- Age
- 55 years to 84 years
- People
- 126 worldwide
- Run by
- ACADIA Pharmaceuticals Inc.
See details and how to joinNCT07095465 · EU 2025-521711-39-00